Press Releases Filter Options Archive DateYear20262025202420232022202120202019201820172016201520142013201220112010200920082007MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember View 12 View 12View 24View 48 Categories CorporateFinancialPrescription MedicinesResearch and PipelineSocial ResponsibilityVaccines Keywords All Keywords Covid-19FinanceInvestmentsLeadershipMedicinesPartnershipsResearchResponsibilityVaccines May 2023 05.18.2023 FDA Advisory Committee Votes in Support of Approval for Pfizer’s Vaccine Candidate to Help Prevent RSV in Infants Through Maternal ImmunizationResearch and PipelineVaccines October 2022 10.04.2022 Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 TrialResearch and PipelineResearch September 2022 09.19.2022 Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European UnionResearch and PipelineResearchVaccines 09.14.2022 Pfizer Initiates Phase 3 Study of mRNA-Based Influenza VaccineResearch and PipelineResearch August 2022 08.08.2022 Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15Research and PipelineResearch June 2022 06.17.2022 Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated PainResearch and PipelineResearch Page 1 Page 2 Page 3 Page 4 Current page 5
